Monocyte-macrophage membrane possesses free radicals scavenging activity: Stimulation by polyphenols or by paraoxonase 1 (PON1)

Free Radical Research

Volumn 47, Issue 4, 2013, Pages 257-267

  Rosenblat, M ^a   Elias, A ^a   Volkova, N ^a   Aviram, M ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Atherosclerosis; DPPH; Oxidative stress; Pomegranate juice; Punicalagin

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ACETYL LOW DENSITY LIPOPROTEIN; ALPHA TOCOPHEROL; ARYLDIALKYLPHOSPHATASE 1; ARYLDIALKYLPHOSPHATASE 2; LIPID PEROXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYPHENOL DERIVATIVE; PUNICALAGIN; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; 2,2-DIPHENYL-1-PICRYLHYDRAZYL; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE; BIPHENYL DERIVATIVE; FREE RADICAL; LOW DENSITY LIPOPROTEIN; PICRIC ACID; POLYPHENOL; PON1 PROTEIN, HUMAN;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CATALYSIS; CELL COUNT; CELL CULTURE; CELL LEVEL; CELL MEMBRANE; CONTROLLED STUDY; DPPH RADICAL SCAVENGING ASSAY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; J774A1 CELL LINE; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; POMEGRANATE JUICE; THP-1 CELL LINE; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG EFFECT; LIPID PEROXIDATION; METABOLISM;

ANIMALS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; BIPHENYL COMPOUNDS; CATALYSIS; CELLS, CULTURED; FREE RADICALS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MACROPHAGES; MICE; MONOCYTES; OXIDATIVE STRESS; PICRATES; POLYPHENOLS;

EID: 84879901346     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2013.765562     Document Type: Article

References (52)

1. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell 2011;145:341-355.
2. Chen K, Keaney JF Jr. Evolving concepts of oxidative stress and reactive oxygen species in cardiovascular disease. Curr Atheroscler Rep 2012;14:476-783.
3. Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 2006;13:129-142.
4. Lee S, Birukov KG, Romanoski CE, Springstead JR, Lusis AJ, Berliner JA. Role of phospholipid oxidation products in atherosclerosis. Circ Res 2012;111:778-799.
5. Kaplan M, Aviram M. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin Chem Lab Med 1999;37:777-787.
6. Rosenblat M, Volkova N, Coleman R, Aviram M. Anti-oxidant and anti-atherogenic properties of liposomal glutathione: studies in vitro, and in the atherosclerotic apolipoprotein E-deficient mice. Atherosclerosis 2007;195:e61-e68.
7. Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, et al. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 2000;71: 1062-1076.
8. Aviram M, Rosenblat M, Gaitini D, Nitecki S, Hoffman A, Dornfeld L, et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr 2004;23:423-433.
9. Gaidukov L, Tawfik DS. High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I. Biochemistry 2005;44:11843-11854.
10. Aviram M, Hardak E, Vaya J, Mahmood S, Milo S, Hoffman A, et al. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities. Circulation 2000;101:2510-2517.
11. Rozenberg O, Shih DM, Aviram M. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. Atherosclerosis 2005;181:9-18.
12. Liu Y, Mackness B, Mackness M. Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress. Free Radic Biol Med 2008;45:743-748.
13. Rosenblat M, Gaidukov L, Khersonsky O, Vaya J, Oren R, Tawfik DS, Aviram M. The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. J Biol Chem 2006;281:7657-7665.
14. Ginsburg I, Kohen R, Koren E. Quantifying oxidant-scavenging ability of blood. N Engl J Med 2011;364:883-885.
15. Dallegri F, Ballestrero A, Ottonello L, Patrone F. Platelets as scavengers of neutrophils-derived oxidants: a possible defence mechanism at sites of vascular injury. Thromb Haemost 1989;61:415-418.
16. Koren E, Kohen R, Ginsburg I. Polyphenols enhance total oxidant-scavenging capacities of human blood by binding to red blood cells. Exp Biol Med 2010;235:689-699.
17. Ginsburg I, Kohen R, Koren E. Microbial and host cells acquire enhanced oxidant-scavenging abilities by binding polyphenols. Arch Biochem Biophys 2011;506:12-23.
18. Aviram M. Plasma lipoprotein separation by discontinuous density gradient unltracentrifugation in hyperlipoproteinemic patients. Biochem Med 1983;30:111-118.
19. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
20. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978;52:302-310.
21. Basu SK, Goldstein JL, Anderson RG, Brown MS. Degradation of cationized LDL and regulation of cholesterol metabolism in homozygous familial hypercholesterolemic fibroblasts. Proc Natl Acad Sci USA 1976;73:3178-3182.
22. Aharoni A, Gaidukov L, Yagur S, Toker L, Silman I, Tawfik DS. Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. Proc Natl Acad Sci USA 2004;101:482-487.
23. Gaidukov L, Tawfik DS. The development of human sera tests for HDL-bound serum PON1 and its lipolactonase activity. J Lipid Res 2007;48:1637-1646.
24. Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol 1983;130:1910-1917.
25. Eierman DF, Johnson CE, Haskill SJ. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J Immunol 1989;142: 1970-1976.
26. LeBel CP, Ischiropoulos H, Bondy SC. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 1992;5:227-231.
27. El-Saadani M, Esterbauer N, El-Sayed M, Goher M, Nassar AY, Jurgens G. Spectrophotometric assay for lipid peroxides in serum lipoproteins using commercially available reagent. J Lipid Res 1989;30:627-630.
28. Vaziri ND, Kim CH, Phan D, Kim S, Liang K. Up-regulation of hepatic acylCoA: diacylglycerol acyltransferase-1 (DGAT1) expression in neophrotic syndrome. Kidney Int 2004;66: 262-267.
29. Oteiza PI, Erlejman AG, Verstraeten SV, Keen CL, Fraga CG. Flavonoid-membrane interactions: a protective role of flavonoids at the membrane surface? Clin Dev Immunol 2005;12: 19-25.
30. Hendrich AB. Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds. Acta Pharmacol Sin 2006;27:27-40.
31. Saija A, Scalese M, Lanza M, Marzullo D, Bonina F, Castelli F. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Radic Biol Med 1995;19: 481-486.
32. Pawlikowska-Pawlega B, Gruszecki WI, Misiak L, Paduch R, Piersiak T, Zarzyka B, et al. Modification of membranes by quercetin, a naturally occurring flavonoid, via its incorporation in the polar head group. Biochim Biophys Acta 2007;1768: 2195-2204.
33. Sanchis-Segura C, Miquel M, Correa M, Aragon CM. The catalase inhibitor sodium azide reduces ethanol-induced loco-motor activity. Alcohol 1999;19:37-42.
34. Del Principe D, Avigliano L, Savini I, Catani MV. Transplasma membrane electron transport in mammals: functional significance in health and disease. Antioxid Redox Signal 2011;14:2289-2318.
35. Medina MA, del Castillo-Olivares A, Núñez de Castro I. Multifunctional plasma membrane redox systems. Bioessays 1997;19:977-984.
36. Ly JD, Lawen A. Transplasma membrane electron transport: enzymes involved and biological function. Redox Rep 2003;8:3-21.
37. Joe B, Lokesh BR. Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1994;1224:255-263.
38. Efrat M, Aviram M. Macrophage paraoxonase 1 (PON1) binding sites. Biochem Biophys Res Commun 2008;376: 105-110.
39. Manach C, Scalbert A, Morand C, Rémésy C, Jiménez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727-747.
40. Lane DJ, Robinson SR, Czerwinska H, Lawen A. A role for Na+/H+ exchangers and intracellular pH in regulating vitamin C-driven electron transport across the plasma membrane. Biochem J 2010;428:191-200.
41. Lane DJ, Lawen A. Ascorbate and plasma membrane electron transport-enzymes vs. efflux. Free Radic Biol Med 2009;47: 485-495.
42. Azzolini C, Fiorani M, Guidarelli A, Cantoni O. Studies with low micromolar levels of ascorbic and dehydroascorbic acid fail to unravel a preferential route for vitamin C uptake and accumulation in U937 cells. Br J Nutr 2012;107:691-696.
43. Harris LK, Mann GE, Ruiz E, Mushtaq S, Leake DS. Ascorbate does not protect macrophages against apoptosis induced by oxidised low density lipoprotein. Arch Biochem Biophys 2006;455:68-76.
44. Shiner M, Fuhrman B, Aviram M. A biphasic U-shape effect of cellular oxidative stress on the macrophage anti-oxidant paraoxonase 2 (PON2) enzymatic activity. Biochem Biophys Res Commun 2006;349:1094-1099.
45. Shiner M, Fuhrman B, Aviram M. Macrophage paraoxonase 2 (PON2) expression is upregulated by unesterified cholesterol through activation of the phosphatidylinositol 3-kinase (PI3K) pathway. Biol Chem 2007;388:1353-1358.
46. Rosenblat M, Volkova N, Paland N, Aviram M. Triglyceride accumulation in macrophages upregulates paraoxonase 2 (PON2) expression via ROS-mediated JNK/c-Jun signaling pathway activation. Biofactors 2012;38:458-469.
47. Ahmed Z, Ravandi A, Maguire GF, Emili A, Draganov D, La Du BN, et al. Multiple Substrates for Paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite. Biochem. Biophys. Res. Commun 2002;290:391-396.
48. Efrat M, Rosenblat M, Mahmood S, Vaya J, Aviram M. Dioleoyl phosphatidylcholine (PC-18:1) stimulates paraoxonase 1 (PON1) enzymatic and biological activities: in vitro and in vivo studies. Atherosclerosis 2009;202:461-469.
49. Nguyen SD, Sok DE. Preferable stimulation of PON1 arylesterase activity by phosphatidylcholines with unsaturated acyl chains or oxidized acyl chains at sn-2 position. Biochim Biophys Acta 2006;1758:499-508.
50. Park CH, Nguyen SD, Kim MR, Jeong TS, Sok DE. Differential effect of lysophospholipids on activities of human plasma paraoxonase1, either soluble or lipid-bound. Lipids 2006;41:371-380.
51. Tavori H, Aviram M, Khatib S, Musa R, Mannheim D, Karmeli R, Vaya J. Human carotid lesion linoleic acid hydroperoxide inhibits paraoxonase 1 (PON1) activity via reaction with PON1 free sulfhydryl cysteine 284. Free Radic Biol Med 2011;50:148-156.
52. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, et al. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med 1999;26:892-904.